SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001085146-23-001078
Filing Date
2023-02-13
Accepted
2023-02-13 12:09:49
Documents
1

Document Format Files

Seq Description Document Type Size
1 CHI ADVISORS LLC inzy_21323.htm SC 13G 26240
  Complete submission text file 0001085146-23-001078.txt   27832
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Subject) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91586 | Film No.: 23616048
SIC: 2834 Pharmaceutical Preparations

Mailing Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022
Business Address 599 LEXINGTON AVENUE 20TH FLOOR NEW YORK NY 10022 2122014829
CHI Advisors LLC (Filed by) CIK: 0001791468 (see all company filings)

IRS No.: 141874283 | State of Incorp.: DE | Fiscal Year End: 1230
Type: SC 13G